Acorda Therapeutics Announces Resignation of COO Mary Fisher

HAWTHORNE, N.Y.--(BUSINESS WIRE)--Acorda Therapeutics, Inc. (NASDAQ: ACOR) announced today the resignation, effective immediately, of Mary Fisher, Chief Operating Officer, to pursue other interests. “All of us at Acorda thank Mary for her many contributions to the Company during the past seven years,” said Ron Cohen, M.D., President and CEO. “She is a person of great talent and accomplishment, and we wish her the best in her future endeavors.”

MORE ON THIS TOPIC